About the Authors
- Jorge Carrillo
-
* E-mail: jcarrillo@irsicaixa.es
Current address: Centre de Recerca en Salut Internacional de Barcelona (CRESIB), Barcelona, Spain
Affiliation Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain
- Luis Manuel Molinos-Albert
-
Affiliations Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
- Maria Luisa Rodríguez de la Concepción
-
Affiliation Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain
- Silvia Marfil
-
Affiliation Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain
- Elisabet García
-
Affiliation Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain
- Ronald Derking
-
Affiliation Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Rogier W. Sanders
-
Affiliations Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America
- Bonaventura Clotet
-
Affiliations Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain, Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Barcelona, Spain, Universitat de Vic-Central de Catalunya, UVIC-UCC, Vic, Barcelona, Spain, Fundació Lluita contra la SIDA, Badalona, Barcelona, Spain
- Julià Blanco
-
Affiliations Institut de Recerca de la SIDA-IrsiCaixa-HIVACAT, Badalona, Barcelona, Spain, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain, Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Barcelona, Spain, Universitat de Vic-Central de Catalunya, UVIC-UCC, Vic, Barcelona, Spain
Competing Interests
BC and JB have received fees for consultancy from BMS, GILEAD, ViiV or Jansen outside the submitted work. The huCD4/mIgG protein is protected by the WO 2014/037490 patent. JC and JB are inventors of the patent WO2014/037490: “Methods for Identifying HIV-1 Neutralizing Antibodies”, in which the assay used for the identification of gp120/CD4 blocking antibodies is described. This does not alter the authors' adherence to Plos One policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JC JB BC. Performed the experiments: JC LMM MLR SM EG. Analyzed the data: JC LMM MLR SM EG. Contributed reagents/materials/analysis tools: RWS RD. Wrote the paper: JC JB LMM.